Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Key Points ++ Disease summary: Approximately 50,000 new cases of renal cell carcinoma (RCC) are diagnosed each year. RCCs are adenocarcinomas derived from renal tubular epithelium. Renal carinoma is comprised of several different types of cancer, each with a different histologic type, with a different clinical course, responding differently to therapy, and caused by different genes. Histologically, there are five subtypes: Conventional (clear cell) (70%-80%) Chromophile (papillary) (10%-15%). Papillary is further classified into type 1 (5%) and type 2 (10% of cases) based on further genetic alterations, histologic, and genetic criteria Chromophobe (3%-5%) Collecting duct (1%) Unclassified (1%) ++ RCC can be hereditary as well as sporadic or nonhereditary. While sporadic RCC is often a solitary lesion and most commonly presents in individuals in their 60s, inherited forms tend to be multifocal, bilateral, and have an earlier onset. ++ Hereditary basis: Renal cancer is hereditary in up to 4% of cases, and follows an autosomal dominant inheritance pattern with incomplete penetrance. In the absence of a diagnosed syndrome, the risk for family members of patients with RCC may increase fivefold. The highest risk appears to be confined to siblings of renal cell cancer patients, arguing for the potential of low penetrance genes acting in concert to elevate the risk of disease. ++ Differential diagnosis: It is important to distinguish the multiorgan system syndromes that include renal cancer as a single feature (ie, von Hippel-Lindau [VHL], Birt-Hogg-Dubé [BHD], and hereditary leiomyomatosis renal cell cancer [HLRCC]) from the familial tumor predispositions (ie, hereditary papillary renal carcinoma [HPRC]), in which renal cancer is the only major finding. Thus, it is imperative to inquire about associated features if there is clinical suspicion for an inherited syndrome in order to establish a clinical diagnosis or indication for genetic (germline) testing (Table 50-1). ++Table Graphic Jump LocationTable 50-1Genetic Differential DiagnosisView Table||Download (.pdf) Table 50-1 Genetic Differential Diagnosis Syndrome Gene Symbol/Locus Associated Findings von Hippel-Lindau VHL/3p25 Hemangioblastomas of the cerebellum, brain stem, spinal cord, and retina; pancreatic and renal cysts, endolymphatic sac tumors, pheochromocytoma, and clear cell carcinoma Hereditary papillary renal carcinoma MET/7q31 Bilateral multifocal type 1 papillary renal cancer, can be later onset (50-70 years) Birt-Hogg-Dubé FLCN/17p11.2 Cutaneous fibrofolliculomas, pulmonary cysts, spontaneous pneumothoraces, multifocal oncocystosis Hereditary leiomyomatosis renal cell cancer FH/1q42.1 Cutaneous and uterine leiomyomas Tuberous sclerosis TSC1/9q34 TSC2/16p13.3 Seizures, mental retardation, angiomyolipoma, hamartomas in multiple organs, clear cell, papillary and chromophobe renal tumors Succinate dehydrogenase, subunit B SDHB/1p36.1-p35 Pheochromocytoma and/or paraganglioma Gene names: VHL, von Hippel-Lindau tumor suppressor; MET, MET proto-oncogene; FLCN, folliculin; FH, fumarate hydratase; TSC1 and TSC2, tuberous sclerosis complex 1 and 2; SDHB, succinate dehydrogenase complex, subunit B iron sulfur. +++ Diagnostic Criteria and Clinical Characteristics +++ Diagnostic Criteria for Hereditary Renal Cancer ++ Inherited forms ... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.